The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Alterations in Macrophage Activation May Signal a Lupus Flare

Alterations in Macrophage Activation May Signal a Lupus Flare

February 11, 2019 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Rheumatologists lack a definitive diagnostic tool to determine whether a patient has systemic lupus erythematous (SLE) and/or when a patient will experience a lupus flare. New data suggest myeloid cells in SLE patients skew B and T cell activation status toward the M1 state, thereby directing flares and remission. The genomic signatures of myeloid cells appear to correlate with and successfully predict SLE disease activity. Although altered myeloid cells gene expression is characteristic of both active and inactive SLE, disease activity was associated with a shift in myeloid cell activation toward the M1 proinflammatory phenotype. The research by Adam C. Labonte, PhD, staff scientist at AMPEL BioSolutions LLC, Charlottesville, Va., and colleagues was published in PLoS One.1

You Might Also Like
  • Macrophage Activation Syndrome
  • 2014 ACR/ARHP Annual Meeting: Macrophage Activation Syndrome
  • New Criteria Released for Macrophage Activation Syndrome in Juvenile Idiopathic Arthritis
Also By This Author
  • Nailfold Videocapillaroscopy Provides a Window into Inflammatory Myopathies

“Here we describe a comprehensive, bioinformatic approach to identify cell type-specific patterns of genetic variation among active and inactive SLE patients and to identify high-priority candidate compounds for drug repositioning efforts,” write the authors in their discussion. “Whereas bioinformatic analysis is often used to supplement studies of SLE pathogenesis in murine models or in vitro, our work represents a novel big data strategy of applying these techniques to patient-derived data in order to identify constellations of genes that might determine clinical outcomes in specific patients.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Researchers performed all their analyses within two Gene Expression Omnibus datasets (GSE10325 and GSE38351). They began with the discovery that myeloid cells in both active and inactive SLE patients have a considerable number of differentially expressed genes compared with healthy controls.

“Our analyses of M1 and M2 signatures indicate that, although there is overlap, M2 gene expression is more prominent in inactive SLE patients, whereas M1 gene expression is highly enhanced in active SLE patients,” write the authors. “This confirms several recent studies that have investigated the roles of Mϕ polarization and DC activation in SLE-like conditions: overabundance of proinflammatory M1 Mϕ and decreased expression of the M2 marker CD206 were detected in both lupus-prone mice and SLE patients, and therapeutic stimulation of M2 polarization significantly decreased disease severity in an induced murine SLE model. However, experimental intervention in M2b polarization, as well as microRNA array profiling, suggest that M2b Mϕ may contribute to SLE severity, indicating that the relationship between Mϕ polarization and lupus progression is more nuanced than it appears at first glance.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

When the researchers used gene set variation analysis to compare expression patterns with their Biologically Informed Gene Clustering database, they found differences in upregulated myeloid cells pathways from patients with active and inactive SLE mirrored and reinforced the M1/M2 signatures observed in the differentially expressed genes. Furthermore, upstream regulator analysis using Ingenuity Pathway Analysis further confirmed this conclusion. However, when researchers attempted to identify biological upstream regulators empirically, they were able to identify several regulators unique to the inactive or active cohort, but were unable to discover polarization-related genes.

Pages: 1 2 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: gene, myeloid cells, SLE, systemic lupus erythematosus (SLE)

You Might Also Like:
  • Macrophage Activation Syndrome
  • 2014 ACR/ARHP Annual Meeting: Macrophage Activation Syndrome
  • New Criteria Released for Macrophage Activation Syndrome in Juvenile Idiopathic Arthritis
  • High-Salt Diet May Trigger Gene Silencing & a Lupus Phenotype

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.